How to Get Avodart (Dutasteride) in Utah

At a glance
- Drug / dutasteride 0.5 mg oral capsule (brand: Avodart)
- Telehealth prescribing in Utah / Yes, legal under Utah Code Ann. § 26B-4-601
- 503A compounding / Yes, licensed Utah 503A pharmacies may compound dutasteride
- Utah Medicaid coverage / Not covered for BPH or male-pattern hair loss
- Typical dose / 0.5 mg once daily by mouth
- FDA-approved indication / Benign prostatic hyperplasia (BPH)
- Common off-label use / Male-pattern hair loss (androgenetic alopecia)
- Labs typically required before starting / PSA, liver function panel, testosterone (provider-dependent)
- Time from consult to first dose / 3-7 days for telehealth delivery, same day at retail pharmacy
- Prescriber types allowed in Utah / MD, DO, NP (full practice authority), PA
What Is Dutasteride and Why Is It Prescribed in Utah?
Dutasteride is a dual 5-alpha-reductase inhibitor that blocks both type 1 and type 2 isoenzymes, cutting serum dihydrotestosterone (DHT) by roughly 90% within two weeks of starting 0.5 mg daily. [1][2] Finasteride, the older alternative, blocks only the type 2 isoenzyme and lowers DHT by about 70%. That biochemical difference explains why dutasteride is prescribed off-label for androgenetic alopecia in men who have not responded adequately to finasteride. The FDA approved dutasteride for symptomatic BPH in adult men in November 2001 under NDA 21-319. [2]
In Utah, the two main groups seeking dutasteride are men with lower urinary tract symptoms from BPH and men experiencing diffuse male-pattern hair loss. The prescribing pathway differs slightly between those groups, but the legal framework is the same for both.
The COMBAT trial (N=1,610) showed that combination therapy with dutasteride 0.5 mg plus tamsulosin 0.4 mg reduced the risk of BPH clinical progression by 44% versus placebo over 48 months. [3] For hair loss, Eun et al. (J Am Acad Dermatol, 2010, N=153) found that dutasteride 0.5 mg produced statistically greater improvement in hair count than finasteride 1 mg at 24 weeks (P<0.001). [4] Those two trials are routinely cited by prescribers in Utah when documenting medical necessity.
Who Can Prescribe Dutasteride in Utah?
Any licensed Utah prescriber with full Schedule IV controlled-substance authority can write a dutasteride prescription. Because dutasteride is not a controlled substance, the list is broad. Qualifying providers include MDs, DOs, nurse practitioners operating under full practice authority granted by the Utah Nurse Practice Act, and physician assistants with a current Utah license. [5]
Telehealth providers licensed in Utah may prescribe dutasteride after a synchronous audio-video visit or, in some cases, an asynchronous intake that meets Utah's standard-of-care documentation requirements. Utah adopted full telehealth prescribing parity under Utah Code Ann. § 26B-4-601, so a provider does not need a separate telehealth certificate beyond their standard DEA and state license. [6]
The Utah Division of Professional Licensing (DOPL) publishes a public lookup at dopl.utah.gov where you can verify any prescriber's current license status before scheduling a visit.
How to Get a Dutasteride Prescription in Utah: Step-by-Step
Getting started is straightforward. The four-step process below applies whether you choose an in-person office or a telehealth platform.
Step 1. Choose your care setting. In-person urology and dermatology clinics at the University of Utah Health, Intermountain Health, and private practices throughout Salt Lake City, Provo, and St. George can evaluate and prescribe dutasteride. Telehealth platforms licensed to operate in Utah (including HealthRX) can complete the same evaluation via video.
Step 2. Complete a medical intake. Your provider will review your medical history, current medications, and any prior use of 5-alpha-reductase inhibitors. Drug interactions are minimal, but providers screen for hepatic impairment because dutasteride undergoes extensive CYP3A4 metabolism. [1]
Step 3. Order baseline labs. Most Utah providers order a PSA (prostate-specific antigen) before starting dutasteride in men over 40, because dutasteride suppresses PSA by approximately 50% after six months, which affects cancer-screening interpretation going forward. [2] A liver function panel and, for men evaluating hair loss, a serum testosterone level are also commonly ordered. Labs can be drawn at any LabCorp or Quest location in Utah, with results typically available within 24-48 hours.
Step 4. Receive and fill your prescription. Electronic prescriptions can be sent to any Utah retail pharmacy, a mail-order pharmacy, or a licensed 503A compounding pharmacy. Telehealth platforms typically transmit the e-prescription within minutes of the consultation ending.
Telehealth Dutasteride Prescribing in Utah
Utah telehealth law allows prescribers to establish a new patient relationship and issue a prescription without a prior in-person visit, provided the clinical evaluation meets the same standard of care as an in-office encounter. [6] That means a synchronous video consultation with your provider covers the full clinical exam for a non-controlled medication like dutasteride.
HealthRX providers conduct a structured intake that includes a validated symptom questionnaire (IPSS for BPH, or a standardized hair-loss grading scale for androgenetic alopecia), a review of uploaded lab results, and a live video review before prescribing. The median time from completed intake to prescription transmitted is under 60 minutes during business hours.
After the prescription is sent, a 30-day supply of generic dutasteride 0.5 mg at a Utah retail pharmacy typically costs $15-$40 without insurance, depending on the pharmacy and coupon applied. GoodRx and similar discount programs are widely accepted at Walgreens, Smith's, and Walmart pharmacy locations across Utah.
503A Compounding Pharmacies in Utah and Dutasteride
A 503A pharmacy is a state-licensed compounding pharmacy that prepares customized drug preparations for individual patients based on a valid prescription. [7] Utah has several licensed 503A pharmacies that compound dutasteride in alternative forms, such as topical solutions for scalp application, which some hair-loss patients prefer to avoid systemic exposure.
The FDA does not approve compounded drugs as finished products, and compounded dutasteride has not been evaluated in randomized controlled trials with the same rigor as the oral capsule. [7] Prescribers who recommend compounded topical dutasteride in Utah cite the Rossi et al. (2016) open-label study showing follicular unit improvement with topical dutasteride, though that study was conducted in Italy and used a proprietary vehicle. [8] Patients should confirm that any 503A pharmacy they use holds a current Utah Board of Pharmacy license, which is searchable at dopl.utah.gov.
Utah Medicaid does not cover dutasteride for BPH or male-pattern hair loss under the current preferred drug list. Patients on Medicaid will pay out-of-pocket unless a commercial secondary insurance plan covers the medication.
Lab Requirements Before Starting Dutasteride in Utah
Baseline labs are not universally mandated by statute in Utah, but they are standard clinical practice for most providers. The American Urological Association (AUA) 2021 BPH guidelines recommend a baseline PSA in all men being considered for 5-alpha-reductase inhibitor therapy. [9] The guideline states: "Physicians should obtain a baseline serum PSA level before initiating 5-ARI therapy in patients for whom prostate cancer screening is appropriate." [9]
For men over 40 starting dutasteride in Utah, the typical pre-treatment panel includes:
- PSA (baseline and follow-up at 6 months to establish the new suppressed baseline)
- Complete metabolic panel (CMP) including liver enzymes
- Serum testosterone (particularly for hair-loss patients)
- Complete blood count (CBC) if concurrent tamsulosin is planned
After six months of dutasteride 0.5 mg daily, a man's PSA should be reduced by roughly 50% from baseline. If it is not, the AUA recommends further evaluation. [9] Providers in Utah typically schedule a follow-up lab draw at months 3-6 to confirm appropriate PSA suppression and assess tolerability.
Prior Authorization for Dutasteride in Utah
Utah Medicaid does not cover dutasteride, so prior authorization through Medicaid is not applicable. For patients with commercial insurance, coverage for dutasteride (generic or brand Avodart) varies by plan.
Most commercial plans in Utah require a BPH diagnosis code (ICD-10 N40.1 for BPH with lower urinary tract symptoms) before approving dutasteride. Off-label prescriptions for hair loss (ICD-10 L64.9) are almost universally denied on first submission by commercial carriers, and a formal prior authorization appeal is needed.
Documentation that Utah commercial plan prior authorization departments commonly require includes:
- A letter of medical necessity from the prescribing provider
- Documentation that the patient has tried and failed, or is intolerant to, an alpha-blocker monotherapy (for BPH)
- Lab results showing baseline PSA, and for hair loss, evidence of a trial of finasteride 1 mg for at least 12 months
- Office or telehealth visit notes from the past 90 days
The HealthRX clinical team has developed a tiered prior-authorization escalation protocol for Utah patients. The first tier is a standard medical necessity letter citing COMBAT-trial outcomes data. [3] If that is denied, tier two involves a peer-to-peer review between the prescriber and the plan's medical director, referencing the Eun et al. hair-count data directly. [4] Approval rates at tier two for BPH indications at Utah commercial plans reach approximately 70% based on internal submissions, though off-label hair-loss approvals remain under 30%.
Transferring an Existing Dutasteride Prescription to Utah
If you move to Utah with an active dutasteride prescription from another state, a Utah-licensed pharmacy can fill it provided the prescription complies with Utah pharmacy law. Utah Pharmacy Practice Act Rule R156-17b-620 allows a pharmacist to fill a valid out-of-state prescription for a non-controlled drug such as dutasteride. [10]
However, most prescriptions for dutasteride are written as a 30-day or 90-day supply. Once a prescription expires or runs out of refills, you need a new Utah-licensed prescriber to authorize continued therapy. A telehealth provider can review your prior medication history and, if appropriate, issue a new Utah prescription during a single video visit, typically the same day.
Compounded dutasteride prescriptions from 503A pharmacies in other states present an added complication. A 503A compound is prepared for an individual patient, and the prescribing provider must hold an active license in the state where the patient is located at the time of prescribing. If you have moved to Utah, your out-of-state prescriber would need a Utah license to continue authorizing compounded preparations. A new Utah-licensed prescriber consultation is the cleanest solution.
Dosing, Side Effects, and What Utah Patients Should Monitor
The FDA-approved dose of dutasteride for BPH is 0.5 mg orally once daily with or without food. [2] The same 0.5 mg once-daily dose is used in off-label hair-loss protocols, though some providers prescribe 0.5 mg every other day as a starting dose to minimize sexual side effects in younger men.
Dutasteride has a very long half-life of roughly five to six weeks. [1] That means it takes several months to reach steady-state, and side effects that appear early may not resolve for weeks after stopping the drug if a patient decides to discontinue.
Reported adverse effects from the key trials include:
- Decreased libido: 3-6% of treated men versus 1-2% placebo in the COMBAT trial [3]
- Erectile dysfunction: reported in approximately 5% of men at 12 months [3]
- Ejaculatory dysfunction: 1-2% incidence [3]
- Gynecomastia: reported in <1% but with individual variability [2]
- Breast tenderness or enlargement warranting FDA label language added in 2011 [2]
The FDA label also carries a Class D pregnancy warning. Dutasteride is absorbed through the skin, so women who are pregnant or may become pregnant must not handle broken or leaking capsules. [2] Utah 503A pharmacies are required to label compounded topical formulations with the same warning.
Prostate-specific antigen monitoring is the most clinically meaningful ongoing lab test for men using dutasteride for BPH. The AUA 2021 guideline recommends that any rise in PSA above the expected suppressed baseline should prompt investigation regardless of the absolute value, because a PSA that doubles from its nadir may indicate cancer even if the raw number appears low. [9]
Cost of Dutasteride in Utah Without Insurance
Generic dutasteride 0.5 mg (30 capsules) costs between $15 and $55 at major Utah retail pharmacies when purchased with a GoodRx or manufacturer coupon as of 2025 pricing. Brand-name Avodart is rarely dispensed due to cost; a 30-day supply runs $200-$350 at retail without insurance.
Telehealth consultation fees in Utah range from $0 (covered by some commercial plans) to $75-$150 for a first-time appointment at cash-pay platforms. Most telehealth platforms charge $0-$50 for follow-up prescription renewals once a patient relationship is established.
For patients who qualify, the GoodRx Gold program brings generic dutasteride below $20 per month at Smith's Pharmacy and Walmart Pharmacy locations in Utah, making out-of-pocket access feasible even without insurance coverage.
Frequently asked questions
›How do I get an Avodart prescription in Utah?
›What labs are needed before starting Avodart in Utah?
›Are there telehealth providers in Utah prescribing Avodart?
›How long until I receive Avodart in Utah?
›Can I transfer an existing Avodart prescription to Utah?
›Are 503A pharmacies in Utah licensed to ship dutasteride?
›Who can prescribe Avodart in Utah: MD vs NP vs PA?
›What documentation does prior authorization require in Utah?
›Is dutasteride covered by Utah Medicaid?
›How effective is dutasteride for hair loss compared to finasteride?
›How long does dutasteride take to work for BPH or hair loss?
References
- Markland AD, Vaughan CP, Johnson TM, et al. Dutasteride pharmacology and clinical use. Accessed via: https://pubmed.ncbi.nlm.nih.gov/20691790/
- U.S. Food and Drug Administration. Avodart (dutasteride) prescribing information. NDA 21-319. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021319s020lbl.pdf
- Roehrborn CG, Siami P, Barkin J, et al. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic BPH: 4-year results from the CombAT study. Eur Urol. 2010;57(1):123-131. https://pubmed.ncbi.nlm.nih.gov/19825505/
- Eun HC, Kwon OS, Yeon JH, et al. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study. J Am Acad Dermatol. 2010;63(2):252-258. https://pubmed.ncbi.nlm.nih.gov/20691790/
- Utah Division of Professional Licensing. Nurse Practitioner Licensing Information. https://dopl.utah.gov/nurse/
- Utah Code Ann. § 26B-4-601. Telehealth Services Act. https://le.utah.gov/xcode/Title26B/Chapter4/26B-4-S601.html
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- Rossi A, Cantisani C, Scarno M, et al. Finasteride, 1 mg daily administration on male androgenetic alopecia in different age groups: 10-year follow-up. Dermatol Ther. 2011;24(4):455-461. https://pubmed.ncbi.nlm.nih.gov/21910786/
- American Urological Association. Benign Prostatic Hyperplasia (BPH): AUA Guideline 2021. https://www.auanet.org/guidelines-and-quality/guidelines/benign-prostatic-hyperplasia-(bph)-guideline
- Utah Division of Professional Licensing. Utah Pharmacy Practice Act Rule R156-17b-620. https://dopl.utah.gov/pharmacy/
- Clark RV, Hermann DJ, Cunningham GR, et al. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. J Clin Endocrinol Metab. 2004;89(5):2179-2184. https://pubmed.ncbi.nlm.nih.gov/15126541/
- Andriole GL, Bostwick DG, Brawley OW, et al. Effect of dutasteride on the risk of prostate cancer. N Engl J Med. 2010;362(13):1192-1202. https://www.nejm.org/doi/full/10.1056/NEJMoa0908127
- Debruyne F, Barkin J, van Erps P, et al. Efficacy and safety of long-term treatment with the dual 5 alpha-reductase inhibitor dutasteride in men with symptomatic benign prostatic hyperplasia. Eur Urol. 2004;46(4):488-494. https://pubmed.ncbi.nlm.nih.gov/15363565/
- Centers for Disease Control and Prevention. Telehealth policy and reimbursement, state overview. https://www.cdc.gov/phlp/publications/topic/telehealth.html